Follow-up of Anterior Cruciate Ligament Reconstruction
1 other identifier
observational
200
1 country
1
Brief Summary
Rupture of Anterior Cruciate Ligament (ACL) is a common pathology, but is subject to variability of associated lesions, surgical management and rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2021
CompletedStudy Start
First participant enrolled
March 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
ExpectedAugust 29, 2024
August 1, 2024
4.5 years
February 25, 2021
August 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Analysis of Magnetic Resonance Imaging (MRI) results
Collected in medical records
Pre-operative and Month: 12
Secondary Outcomes (4)
Analysis of operative report results
Month: 12
Analysis of consultation report
pre-operative and Months: 1,5 , 3, 6, 12
Analysis of isokinetic tests
Months: 9, 12
Analysis of clinical surveys
pre-operative and Months: 3, 6, 12
Study Arms (1)
Patients having undergone an Anterior Cruciate Ligament (ACL) reconstruction
Patients having undergone an ACL reconstruction will be included.
Interventions
data collection in history medical : operative report, clinical examination, questionnaires, imaging, isokinetic tests
Eligibility Criteria
Patients having undergone an Anterior Cruciate Ligament (ACL) reconstruction will be included.
You may qualify if:
- Patients having undergone an Anterior Cruciate Ligament (ACL) reconstruction
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Saint-Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas NERI, MD
CHU SAINT-ETIENNE
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2021
First Posted
March 4, 2021
Study Start
March 1, 2021
Primary Completion
September 1, 2025
Study Completion (Estimated)
September 1, 2027
Last Updated
August 29, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share